Responses to parliamentary questions
Question from Deputy Eoghan Kenny - PQ 29555-26
Deputy Kenny asked about the inclusion of skyclarys (omaveloxolone) in a reimbursement scheme. Read the HSE response.
From: Communications and public affairs
Published: April 2026
Updated: May 2026
Documents
Question from Deputy Eoghan Kenny - PQ 29555-26
PDF, 230KB, 3 pages
Summary
To ask the Minister for Health if her Department has considered the inclusion of skyclarys (omaveloxolone) which is a treatment for Friedreich's ataxia in a reimbursement scheme given the cost of the drug and the fact that other European countries provide this scheme to patients; and if she will make a statement on the matter.
This is a beta version - your feedback will help us to improve it